Wacker and MorphoSys expand Cooperation to use Wacker's ESETEC Technology for Production of Antigen Material

22-Jan-2010 - Germany

Wacker Chemie AG and MorphoSys AG announced an expansion of their existing cooperation in the use of Wacker s bacterial secretion technology ESETEC®. As a result, MorphoSys will now be able to use the Wacker technology for the production of antigen material in addition to the production of antibodies in both the early development phase of therapeutic projects as well as in the production of diagnostic and research antibodies. The technology complements MorphoSys’s existing production platforms. It could offer significant advantages with regard to the production of novel antigens, which have proven difficult to produce with conventional expression systems.

”The extension of our existing collaboration with MorphoSys underpins the success of our protein production technology ESETEC®“, said Dr. Thomas Maier, Managing Director at Wacker Biotech GmbH, Wacker Chemie AG’s subsidiary for custom manufacturing of biopharmaceuticals. “Since we introduced this innovation to the biopharmaceutical market we see that more and more companies revisit E. coli as production host to benefit from shorter development timelines”, he added.

Other news from the department business & finance

These products might interest you

Tailor-made products for specific applications

Tailor-made products for specific applications by IPC Process Center

Granulates and pellets - we develop and manufacture the perfect solution for you

Agglomeration of powders, pelletising of powders and fluids, coating with melts and polymers

toll manufacturing
Custom qPCR and dPCR primers and PCR assay development.

Custom qPCR and dPCR primers and PCR assay development. by Microsynth

Assay Design, Validation and Analysis - Primers and Probes for qPCR and dPCR Applications

High-quality qPCR and dPCR probes, extensive experience in assay design, development and validation

PCR reagents
Loading...

Most read news

More news from our other portals

So close that even
molecules turn red...

See the theme worlds for related content

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

View topic world
Topic world Antibodies

Topic world Antibodies

Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous